PERSPECTA

News from every angle

Back to headlines

AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference

6 Mar, 02:07 — 6 Mar, 02:07
PostShare

Sources

Showing 1 of 1 sources